- Home
- TOPS vs CARA Comparison
TOPS vs CARA Comparison
Compare TOPS & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- CARA
- Stock Information
- Founded
- TOPS 2000
- CARA 2004
- Country
- TOPS Greece
- CARA United States
- Employees
- TOPS N/A
- CARA N/A
- Industry
- TOPS Marine Transportation
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- TOPS Consumer Discretionary
- CARA Health Care
- Exchange
- TOPS Nasdaq
- CARA Nasdaq
- Market Cap
- TOPS 28.3M
- CARA 23.6M
- IPO Year
- TOPS 2004
- CARA 2014
- Fundamental
- Price
- TOPS $6.46
- CARA $5.10
- Analyst Decision
- TOPS
- CARA Hold
- Analyst Count
- TOPS 0
- CARA 3
- Target Price
- TOPS N/A
- CARA $12.00
- AVG Volume (30 Days)
- TOPS 8.7K
- CARA 10.4K
- Earning Date
- TOPS 04-15-2025
- CARA 05-12-2025
- Dividend Yield
- TOPS N/A
- CARA N/A
- EPS Growth
- TOPS N/A
- CARA N/A
- EPS
- TOPS N/A
- CARA N/A
- Revenue
- TOPS $83,870,000.00
- CARA $7,137,000.00
- Revenue This Year
- TOPS $7.10
- CARA N/A
- Revenue Next Year
- TOPS $6.54
- CARA N/A
- P/E Ratio
- TOPS N/A
- CARA N/A
- Revenue Growth
- TOPS 1.10
- CARA N/A
- 52 Week Low
- TOPS $5.30
- CARA $2.71
- 52 Week High
- TOPS $14.24
- CARA $11.39
- Technical
- Relative Strength Index (RSI)
- TOPS 63.70
- CARA 49.07
- Support Level
- TOPS $6.33
- CARA $4.88
- Resistance Level
- TOPS $6.54
- CARA $5.15
- Average True Range (ATR)
- TOPS 0.19
- CARA 0.26
- MACD
- TOPS 0.05
- CARA -0.04
- Stochastic Oscillator
- TOPS 74.47
- CARA 25.89
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.